Biomerica, Inc. (BMRA) is a Medical - Devices company in the Healthcare sector, currently trading at $2.10. It has a SharesGrow Score of 46/100, indicating a mixed investment profile with 3 out of 7 criteria passed.
Valuation: BMRA trades at a trailing Price-to-Earnings (P/E) of -1.5 (S&P 500 average ~25) with a forward Price/Earnings-to-Growth (PEG) of 0.01.
Financials: revenue is $5M, -24.1%/yr average growth. Net income is $5M (loss), growing at -8.2%/yr. Net profit margin is -93.6% (negative). Gross margin is 9.4% (-6.4 pp trend).
Balance sheet: total debt is $458,000 against $4M equity (Debt-to-Equity (D/E) ratio 0.11, conservative). Current ratio is 2.8 (strong liquidity). Debt-to-assets is 7.7%. Total assets: $6M.
Analyst outlook: 3 / 3 analysts rate BMRA as buy (100%) — strong consensus.
SharesGrow 7-Criteria breakdown: Value 100/100 (Pass), Growth 15/100 (Fail), Past 0/100 (Fail), Health 100/100 (Pass), Moat 0/100 (Fail), Future 100/100 (Pass), Income 10/100 (Fail).
